We are delighted to announce that Pauli Wong, Partner at Eagle IP, has been invited to speak at the Entrepreneurship Series 2026, organized by the Hong Kong Life Sciences Society (HKLSS).

Pauli will lead an essential session titled "Protecting Innovation through IP and Legal Strategy," tailored specifically for the next generation of life sciences entrepreneurs, researchers, and biotech professionals. In an industry where intellectual property is often the most valuable asset a company owns, this seminar aims to equip participants with the strategic mindset needed to safeguard their scientific breakthroughs.

At Eagle IP, we are committed to empowering the local life sciences ecosystem. We are proud to partner with HKLSS in their mission to nurture talent and bridge the gap between academic excellence and commercial success in the life sciences sector.

Our Past Events

Recommended Insights

China Releases Draft Examination Guidelines for the new Patent Law

4 December 2020
The Chinese Patent Office (CNIPA) is moving forward at breakneck speeds aiming to get all the necessary pieces in place for the June 1, 2021 date when the new 4th Amendment of the Patent Law will come into effect. Most recently, this means a flurry of drafts coming out from CNIPA, including, but not limited […]

What Kind of Damage Awards Can You Get in China?

16 June 2022
Is it worth filing for a patent in China? What kind of damage awards can you get? Pharma companies care more about injunction than damage awards, since it’s quite unlikely that any damage award can compensate for the large amounts of money that may be lost for patent infringement. Chinese courts often issue injunctions in […]

How Smart is a "Skilled Person in the Art"?

11 April 2022
Let’s start with a riddle: can you name a person who has read every book, every journal, conducted every known experiment, and is knowledgeable about every single patent prosecution / litigation in the world? The answer? A “skilled person in the art.” This person is also known as a “person having ordinary skill in the […]

China Top 10 Cases of 2020 – CNIPA Upholds Second Medical Use Patent from University of Bordeaux

24 May 2021
The development of China’s approach to patents, especially those in the pharmaceutical and biotech space, has been fascinating to watch. Those of us who have practiced in the area for a long time have been frustrated by the Chinese patent office’s overly strict rules regarding patentability (e.g., high data support standard and refusal to consider […]
Top crossarrow-right